Table 1 Demographic and tumors characteristics of vaccinated patients by study
Demographic Characteristics | Study (Vaccine Arms) | |
|---|---|---|
Phase II Trial | Phase III Trial | |
Age | ||
Total | 40 (100%) | 40 (100%) |
< 60 | 30 (75%) | 25 (62.5%) |
> 60 | 10 (25%) | 15 (37.5%) |
Race | 34 (85%) | 32 (80%) |
White | 34 (85%) | 32 (80 %) |
African Descendants | 1 (2.5%) | 6 (15%) |
Other | 5 (12.5%) | 2 (5%) |
Sex | ||
F | 10 (25%) | 27 (31.8%) |
M | 30 (75%) | 57 (68.2%) |
Stage | ||
IIIB | 29 (72.5%) | 56 (67.4%) |
IV | 11 (27.5%) | 28 (32.6%) |
Histological Type | ||
ADC | 12 (30.8%) | 32 (38.6%) |
No ADC | 27 (67.5%) | 52 (61.4%) |
ECOG | ||
0 | 9 (23%) | 35 (40.4%) |
1 | 24 (62%) | 43 (50.6%) |
2 | 6 (15%) | 6 (7.9%) |